Elekta AB (publ) (EKTAY)
USD 5.07
(0.35%)
USD 5.07
(0.35%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 1.3 Billion SEK | 38.07% |
| 2023 | 943 Million SEK | -18.28% |
| 2022 | 1.15 Billion SEK | -7.97% |
| 2021 | 1.25 Billion SEK | 15.68% |
| 2020 | 1.08 Billion SEK | -9.52% |
| 2019 | 1.19 Billion SEK | 9.01% |
| 2018 | 1.09 Billion SEK | 779.2% |
| 2017 | 125 Million SEK | -8.76% |
| 2016 | 137 Million SEK | -75.18% |
| 2015 | 552 Million SEK | -51.92% |
| 2014 | 1.14 Billion SEK | -14.33% |
| 2013 | 1.34 Billion SEK | 9.21% |
| 2012 | 1.22 Billion SEK | 19.01% |
| 2011 | 1.03 Billion SEK | 23.77% |
| 2010 | 833 Million SEK | 52.56% |
| 2009 | 546 Million SEK | 34.48% |
| 2008 | 406 Million SEK | 16.67% |
| 2007 | 348 Million SEK | 14.47% |
| 2006 | 304 Million SEK | 20.16% |
| 2005 | 253 Million SEK | 2.02% |
| 2004 | 248 Million SEK | 5.98% |
| 2003 | 234 Million SEK | 61.38% |
| 2002 | 145 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 344 Million SEK | 44.54% |
| 2024 Q4 | 415 Million SEK | 36.07% |
| 2024 Q1 | 238 Million SEK | -56.41% |
| 2024 Q3 | 305 Million SEK | -11.34% |
| 2024 FY | 1.3 Billion SEK | 38.07% |
| 2023 Q1 | 60 Million SEK | -85.58% |
| 2023 Q2 | 122 Million SEK | 103.33% |
| 2023 Q4 | 546 Million SEK | 152.78% |
| 2023 Q3 | 216 Million SEK | 77.05% |
| 2023 FY | 943 Million SEK | -18.28% |
| 2022 Q1 | 127 Million SEK | -62.76% |
| 2022 Q3 | 229 Million SEK | -40.21% |
| 2022 FY | 1.15 Billion SEK | -7.97% |
| 2022 Q4 | 416 Million SEK | 81.66% |
| 2022 Q2 | 383 Million SEK | 201.57% |
| 2021 Q2 | 375 Million SEK | 73.61% |
| 2021 Q1 | 216 Million SEK | -47.06% |
| 2021 Q4 | 341 Million SEK | 5.9% |
| 2021 Q3 | 322 Million SEK | -14.13% |
| 2021 FY | 1.25 Billion SEK | 15.68% |
| 2020 Q2 | 221 Million SEK | 50.34% |
| 2020 Q4 | 408 Million SEK | 32.47% |
| 2020 Q1 | 147 Million SEK | -72.57% |
| 2020 Q3 | 308 Million SEK | 39.37% |
| 2020 FY | 1.08 Billion SEK | -9.52% |
| 2019 Q2 | 285 Million SEK | 71.69% |
| 2019 Q4 | 536 Million SEK | 154.03% |
| 2019 Q3 | 211 Million SEK | -25.96% |
| 2019 Q1 | 166 Million SEK | -69.49% |
| 2019 FY | 1.19 Billion SEK | 9.01% |
| 2018 Q2 | 247 Million SEK | 24800.0% |
| 2018 FY | 1.09 Billion SEK | 779.2% |
| 2018 Q1 | -1 Million SEK | -101.08% |
| 2018 Q4 | 544 Million SEK | 76.62% |
| 2018 Q3 | 308 Million SEK | 24.7% |
| 2017 Q1 | -65 Million SEK | -185.53% |
| 2017 Q4 | 93 Million SEK | 121.43% |
| 2017 FY | 125 Million SEK | -8.76% |
| 2017 Q3 | 42 Million SEK | -23.64% |
| 2017 Q2 | 55 Million SEK | 184.62% |
| 2016 Q3 | 4 Million SEK | -97.87% |
| 2016 FY | 137 Million SEK | -75.18% |
| 2016 Q1 | -131 Million SEK | -138.42% |
| 2016 Q4 | 76 Million SEK | 1800.0% |
| 2016 Q2 | 188 Million SEK | 243.51% |
| 2015 FY | 552 Million SEK | -51.92% |
| 2015 Q4 | 341 Million SEK | 127.33% |
| 2015 Q3 | 150 Million SEK | -24.24% |
| 2015 Q2 | 198 Million SEK | 244.53% |
| 2015 Q1 | -137 Million SEK | -116.75% |
| 2014 Q4 | 818 Million SEK | 456.46% |
| 2014 FY | 1.14 Billion SEK | -14.33% |
| 2014 Q1 | -6 Million SEK | -100.71% |
| 2014 Q2 | 189 Million SEK | 3250.0% |
| 2014 Q3 | 147 Million SEK | -22.22% |
| 2013 Q4 | 843 Million SEK | 266.52% |
| 2013 FY | 1.34 Billion SEK | 9.21% |
| 2013 Q1 | 12 Million SEK | -97.79% |
| 2013 Q2 | 255 Million SEK | 2025.0% |
| 2013 Q3 | 230 Million SEK | -9.8% |
| 2012 Q1 | 46 Million SEK | -91.34% |
| 2012 Q3 | 390 Million SEK | 56.63% |
| 2012 Q2 | 249 Million SEK | 441.3% |
| 2012 Q4 | 544 Million SEK | 39.49% |
| 2012 FY | 1.22 Billion SEK | 19.01% |
| 2011 Q2 | 202 Million SEK | 96.12% |
| 2011 FY | 1.03 Billion SEK | 23.77% |
| 2011 Q1 | 103 Million SEK | -78.32% |
| 2011 Q3 | 195 Million SEK | -3.47% |
| 2011 Q4 | 531 Million SEK | 172.31% |
| 2010 Q2 | 155 Million SEK | 176.79% |
| 2010 Q1 | 56 Million SEK | 0.0% |
| 2010 Q3 | 147 Million SEK | -5.16% |
| 2010 FY | 833 Million SEK | 52.56% |
| 2010 Q4 | 475 Million SEK | 223.13% |
| 2009 FY | 546 Million SEK | 34.48% |
| 2008 FY | 406 Million SEK | 16.67% |
| 2007 FY | 348 Million SEK | 14.47% |
| 2006 FY | 304 Million SEK | 20.16% |
| 2005 FY | 253 Million SEK | 2.02% |
| 2004 FY | 248 Million SEK | 5.98% |
| 2003 FY | 234 Million SEK | 61.38% |
| 2002 FY | 145 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 140569.288% |
| Ansell Limited | 76.5 Million USD | -1601.961% |
| Ansell Limited | 76.5 Million USD | -1601.961% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -5262.394% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 79965.394% |
| Psykey, Inc. | -1.32 Million USD | 98442.008% |
| ConvaTec Group Plc | 130.3 Million USD | -899.233% |
| ConvaTec Group Plc | 130.3 Million USD | -899.233% |
| Encision Inc. | -691.78 Thousand USD | 188309.308% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 918223.418% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 555641.333% |
| Innovative MedTech Inc. | -7.93 Million USD | 16500.263% |
| LifePoint, Inc. | -15.23 Million USD | 8648.02% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 19216.136% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 274783.544% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 474510.267% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 283742.828% |
| SmileDirectClub, Inc. | -86.4 Million USD | 1606.875% |
| Sector 10, Inc. | 7036.00 USD | -18504732.291% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 34.962% |
| SheerVision, Inc. | -71.37 Thousand USD | 1824242.569% |
| United Health Products, Inc. | -2.62 Million USD | 49732.767% |
| Vasamed, Inc. | -4.88 Million USD | 26735.827% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 54611.953% |
| Yubo International Biotech Limited | -1.2 Million USD | 108170.869% |